Product Comparison


 
Glaxo Smith Kline 58160081912
Glaxo Smith Kline 58160082311
McKesson # 1080947 1081079
Description Shingrix® Shingles Vaccine 50 Years of Age and Older Zoster Vaccine Recombinant, Adjuvanted 50 mcg / 0.5 mL Injection Single Dose Vial Kit 1 Dose Shingrix® Shingles Vaccine 50 Years of Age and Older Zoster Vaccine Recombinant, Adjuvanted 50 mcg / 0.5 mL Injection Single Dose Vial Kit 10 Doses
Manufacturer # 5816008191258160082311
Brand Shingrix®Shingrix®
Manufacturer Glaxo Smith KlineGlaxo Smith Kline
Invoice SHINGRIX VACC, SDV 50MCG/0.5ML0.5MLSHINGRIX VACC, SDV 50MCG/0.5ML0.5ML (10/BX)
    Log In to Order   Log In to Order

Comparison

NDC Number 5816008191258160082311
UNSPSC Code 5120165051201600
Volume 1 Dose10 Doses
Application Shingles VaccineShingles Vaccine
Container Type Single Dose Vial KitSingle Dose Vial Kit
Country of Origin UnknownUnknown
Dosage Form InjectionInjection
Generic Drug Code 4398943989
Generic Drug Name Zoster Vaccine Recombinant, AdjuvantedZoster Vaccine Recombinant, Adjuvanted
Product Dating McKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements Requires RefrigerationRequires Refrigeration
Strength 50 mcg / 0.5 mL50 mcg / 0.5 mL
Type IntramuscularIntramuscular
User 50 Years of Age and Older50 Years of Age and Older
Features and Benefits
  • SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older
  • SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox)
  • SHINGRIX is supplied as 2 components: A single-dose vial of lyophilized gE antigen component (brown cap) and a single-dose vial of adjuvant suspension component (blue-green cap) (packaged without syringes or needles)
  • A single dose after reconstitution is 0.5 mL
  • Administer 2 doses (0.5 mL each) at 0 and 2 to 6 months
  • SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older
  • SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox)
  • SHINGRIX is supplied as 2 components: A single-dose vial of lyophilized gE antigen component (brown cap) and a single-dose vial of adjuvant suspension component (blue-green cap) (packaged without syringes or needles)
  • A single dose after reconstitution is 0.5 mL
  • Administer 2 doses (0.5 mL each) at 0 and 2 to 6 months